Zomedica Pharmaceuticals (ZOM) Sets New 12-Month Low at $1.08
Zomedica Pharmaceuticals Corp (CVE:ZOM) shares reached a new 52-week low during trading on Wednesday . The stock traded as low as C$1.08 and last traded at C$1.08, with a volume of 2000 shares changing hands. The stock had previously closed at C$1.31.
The stock has a market cap of $132.47 million and a P/E ratio of -5.56.
About Zomedica Pharmaceuticals (CVE:ZOM)
Zomedica Pharmaceuticals Corp., a development stage veterinary diagnostic and pharmaceutical company, engages in the discovery, development, and commercialization of pharmaceuticals for the companion pet. The company's lead drug product candidate is ZM-012, a tablet formulation of metronidazole targeting the treatment of acute diarrhea in dogs.
Receive News & Ratings for Zomedica Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zomedica Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.